CEACAM5 and non-small cell lung carcinoma: Cyfra21-1, carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC) and tissue polypeptide antigen (TPA) are biomarkers being applied in the clinical diagnosis of NSCLC.